Characterization of patients with ocular myasthenia gravis — A case series

eNeurologicalSci - Tập 4 - Trang 30-33 - 2016
Arnon Karni1, Ali Asmail1, Vivian E. Drory2, Hadar Kolb1, Anat Kesler3
1Neuroimmunology Clinic, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Neuromuscular Service of the Department of Neurology, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Neuro-ophthalmology Unit of the Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Tài liệu tham khảo

Vincent, 1985, Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays, J. Neurol. Neurosurg. Psychiatry, 48, 1246, 10.1136/jnnp.48.12.1246 Lewis, 1995, Myasthenia gravis: immunological mechanisms and immunotherapy, Ann. Neurol., 37, S51, 10.1002/ana.410370707 Berrih-Aknin, 2014, Diagnostic and clinical classification of autoimmune myasthenia, J. Autoimmun., 48-49, 143, 10.1016/j.jaut.2014.01.003 Drachman, 1994, Myasthenia gravis, N. Engl. J. Med., 330, 1797, 10.1056/NEJM199406233302507 Luchanok, 2008, Ocular myasthenia: diagnostic and treatment recommendations and the evidence base, Curr. Opin. Neurol., 21, 8, 10.1097/WCO.0b013e3282f4098e Kerty, 2014, EFNS/ENS guidelines for the treatment of ocular myasthenia gravis, Eur. J. Neurol., 21, 687, 10.1111/ene.12359 Gilhus, 2015, Myasthenia gravis: subgroup classification and therapeutic strategies, Lancet Neurol., 14, 1023, 10.1016/S1474-4422(15)00145-3 Gwathmey, 2015, Myasthenia gravis, Semin. Neurol., 35, 327, 10.1055/s-0035-1558975 Grob, 2008, Lifetime course of myasthenia gravis, Muscle Nerve, 37, 141, 10.1002/mus.20950 Zhang, 2007, Clinical and serological study of myasthenia gravis in HuBei Province, China J. Neurol. Neurosurg. Psychiatry, 78, 386, 10.1136/jnnp.2006.100545 Meriggioli, 2009, Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity, Lancet Neurol., 8, 475, 10.1016/S1474-4422(09)70063-8 Oh, 2009, Racial differences in myasthenia gravis in Alabama, Muscle Nerve, 39, 328, 10.1002/mus.21191 Juel, 2007, Orphanet J. Rare Dis., 2, 1, 10.1186/1750-1172-2-44 Pillai, 2013, Rethinking mechanisms of autoimmune pathogenesis, J. Autoimmun., 45, 97, 10.1016/j.jaut.2013.05.003 Itoh, 1999, Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance, J. Immunol., 162, 5317, 10.4049/jimmunol.162.9.5317 Marx, 2013, The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes, Autoimmun. Rev., 12, 875, 10.1016/j.autrev.2013.03.007 Kaminski, 2000, Treatment of ocular myasthenia: steroids only when compelled, Arch. Neurol., 57, 752, 10.1001/archneur.57.5.752 Beekman, 1997, Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients, J. Neurol., 244, 112, 10.1007/s004150050059 Phillips, 1990, Diagnosis of myasthenia gravis in the 1990s, Semin. Neurol., 10, 62, 10.1055/s-2008-1041255 Daroff, 1986, The office tensilon test for ocular myasthenia gravis, Arch. Neurol., 33, 843, 10.1001/archneur.1986.00520080081029 Libman, 2002, Myasthenia mimicking vertebrobasilar stroke, J. Neurol., 249, 1512, 10.1007/s00415-002-0858-2